Alternative splicing of SMADs in differentiation and tissue homeostasis

Development Growth and Differentiation

Volumn 52, Issue 4, 2010, Pages 335-342

  Tao, Shijie ^a   Sampath, Karuna ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

RNA splicing; SMADs; TGF SMAD signalling; Tissue homeostasis

Indexed keywords

ISOPROTEIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ALTERNATIVE RNA SPLICING; AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; DEVELOPMENTAL BIOLOGY; GENE EXPRESSION REGULATION; GENE MUTATION; HOMEOSTASIS; HUMAN; NONHUMAN; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN VARIANT; REVIEW; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HOMEOSTASIS; HUMANS; PROTEIN ISOFORMS; SMAD PROTEINS; SMAD5 PROTEIN;

EID: 77951745344     PISSN: 00121592     EISSN: 1440169X     Source Type: Journal    
DOI: 10.1111/j.1440-169X.2009.01163.x     Document Type: Review

References (56)

1. Attisano, L. Wrana, J. L. 2002. Signal transduction by the TGF-beta superfamily. Science 296, 1646 1647.
2. Aubin, J., Davy, A. Soriano, P. 2004. In vivo convergence of BMP and MAPK signaling pathways: impact of differential SMAD1 phosphorylation on development and homeostasis. Genes Dev. 18, 1482 1494. (Pubitemid 38780633)
3. Caceres, J. F. Kornblihtt, A. R. 2002. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet. 18, 186 193.
4. Chen, Y. G. Massague, J. 1999. SMAD1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J. Biol. Chem. 274, 3672 3677. (Pubitemid 29077212)
5. Cheng, K. H., Ponte, J. F. Thiagalingam, S. 2004. Elucidation of epigenetic inactivation of SMAD8 in cancer using targeted expressed gene display. Cancer Res. 64, 1639 1646. (Pubitemid 38428684)
6. Christian, J. L. Nakayama, T. 1999. Can't get no SMADisfaction: SMAD proteins as positive and negative regulators of TGF-beta family signals. Bioessays 21, 382 390. (Pubitemid 29223310)
7. De Caestecker, M. P., Piek, E. Roberts, A. B. 2000. Role of transforming growth factor-beta signaling in cancer. J. Natl Cancer Inst. 92, 1388 1402.
8. De Winter, J. P., Roelen, B. A., Ten Dijke, P., Van Der Burg, B. Van Den Eijnden-Van Raaij, A. J. 1997. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14, 1891 1899. (Pubitemid 27217802)
9. Dennler, S., Huet, S. Gauthier, J. M. 1999. A short amino-acid sequence in MH1 domain is responsible for functional differences between SMAD2 and SMAD3. Oncogene 18, 1643 1648. (Pubitemid 29108066)
10. Derynck, R. Zhang, Y. E. 2003. SMAD-dependent and SMAD-independent pathways in TGF-beta family signalling. Nature 425, 577 584. (Pubitemid 37280136)
11. Dunn, N. R., Koonce, C. H., Anderson, D. C., Islam, A., Bikoff, E. K. Robertson, E. J. 2005. Mice exclusively expressing the short isoform of SMAD2 develop normally and are viable and fertile. Genes Dev. 19, 152 163. (Pubitemid 40095824)
12. Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T. Miyazono, K. 2001. Smurf1 interacts with transforming growth factor-beta type I receptor through SMAD7 and induces receptor degradation. J. Biol. Chem. 276, 12477 12480. (Pubitemid 37385151)
13. Grimm, O. H. Gurdon, J. B. 2002. Nuclear exclusion of SMAD2 is a mechanism leading to loss of competence. Nat. Cell Biol. 4, 519 522.
14. Hata, A., Lagna, G., Massague, J. Hemmati-Brivanlou, A. 1998. SMAD6 inhibits BMP/SMAD1 signaling by specifically competing with the SMAD4 tumor suppressor. Genes Dev. 12, 186 197. (Pubitemid 28060449)
15. Heldin, C. H., Miyazono, K. Ten Dijke, P. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465 471. (Pubitemid 28013118)
16. Hohenstein, P., Molenaar, L., Elsinga, J., Morreau, H., van der Klift, H., Struijk, A., Jagmohan-Changur, S., Smits, R., van Kranen, H., van Ommen, G. J., Cornelisse, C., Devilee, P. Fodde, R. 2003. Serrated adenomas and mixed polyposis caused by a splice acceptor deletion in the mouse SMAD4 gene. Genes Chromosomes Cancer 36, 273 282. (Pubitemid 36158200)
17. Itoh, S. Ten Dijke, P. 2007. Negative regulation of TGF-beta receptor/SMAD signal transduction. Curr. Opin. Cell Biol. 19, 176 184. (Pubitemid 46386411)
18. Jiang, Y., Liang, H., Guo, W., Kottickal, L. V. Nagarajan, L. 2000. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia. Blood 95, 3945 3950. (Pubitemid 30412872)
19. Jones, J. B. Kern, S. E. 2000. Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4. Nucleic Acids Res. 28, 2363 2368. (Pubitemid 30349041)
20. Jurica, M. S. Moore, M. J. 2003. Pre-mRNA splicing: awash in a sea of proteins. Mol. Cell 12, 5 14.
21. Kageyama, H., Seki, N., Yamada, S., Sakiyama, S. Nakagawara, A. 1998. DPC4 splice variants in neuroblastoma. Cancer Lett. 122, 187 193. (Pubitemid 28058635)
22. Kambach, C., Walke, S. Nagai, K. 1999. Structure and assembly of the spliceosomal small nuclear ribonucleoprotein particles. Curr. Opin. Struct. Biol. 9, 222 230. (Pubitemid 29452902)
23. Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H. Wrana, J. L. 2000. SMAD7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365 1375. (Pubitemid 32045929)
24. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T. Miyazono, K. 1998. SMAD proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17, 4056 4065. (Pubitemid 28333989)
25. Kjellman, C., Honeth, G., Jarnum, S., Lindvall, M., Darabi, A., Nilsson, I., Edvardsen, K., Salford, L. G. Widegren, B. 2004. Identification and characterization of a human smad3 splicing variant lacking part of the linker region. Gene 327, 141 152. (Pubitemid 38230110)
26. Konrad, L., Scheiber, J. A., Bergmann, M., Eickelberg, O. Hofmann, R. 2008. Identification of a new human SMAD6 splice variant. Andrologia 40, 358 363.
27. Kramer, A. 1996. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu. Rev. Biochem. 65, 367 409. (Pubitemid 26250614)
28. Kretzschmar, M., Doody, J. Massague, J. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator SMAD1. Nature 389, 618 622. (Pubitemid 27446181)
29. Lamond, A. I. 1993. The spliceosome. Bioessays 15, 595 603.
30. Lazzereschi, D., Nardi, F., Turco, A. Ottini, L., D'Amico, C., Mariani-Costantini, R., Gulino, A. Coppa, A. 2005. A complex pattern of mutations and abnormal splicing of SMAD4 is present in thyroid tumours. Oncogene 24, 5344 5354. (Pubitemid 43080104)
31. Lee, H. G., Ueda, M., Zhu, X., Perry, G. Smith, M. A. 2006. Ectopic expression of phospho-SMAD2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway? J. Neurosci. Res. 84, 1856 1861. (Pubitemid 44892619)
32. Li, M., Li, J., Hoodless, P. A., Tzukazaki, T., Wrana, J. L., Attisano, L. Tsang, B. K. 1997. Mothers against decapentaplegic-related protein 2 expression in avian granulosa cells is up-regulated by transforming growth factor beta during ovarian follicular development. Endocrinology 138, 3659 3665. (Pubitemid 27351914)
33. Luo, J., Lin, A. H., Masliah, E. Wyss-Coray, T. 2006. Bioluminescence imaging of SMAD signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc. Natl. Acad. Sci. U S A 103, 18326 18331. (Pubitemid 44871657)
34. Maru, D., Wu, T. T., Canada, A., Houlihan, P. S., Hamilton, S. R. Rashid, A. 2004. Loss of chromosome 18q and DPC4 (SMAD4) mutations in appendiceal adenocarcinomas. Oncogene 23, 859 864. (Pubitemid 38241288)
35. Massague, J., Blain, S. W. Lo, R. S. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103, 295 309.
36. Massague, J., Seoane, J. Wotton, D. 2005. SMAD transcription factors. Genes Dev. 19, 2783 2810. (Pubitemid 41739965)
37. Miyazono, K., Maeda, S. Imamura, T. 2005. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251 263. (Pubitemid 40910315)
38. Moore, P. S., Orlandini, S., Zamboni, G., Capelli, P., Rigaud, G., Falconi, M., Bassi, C., Lemoine, N. R. Scarpa, A. 2001. Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. Br. J. Cancer 84, 253 262. (Pubitemid 32113454)
39. Moustakas, A., Souchelnytskyi, S. Heldin, C. H. 2001. SMAD regulation in TGF-beta signal transduction. J. Cell Sci. 114, 4359 4369. (Pubitemid 34082857)
40. Murakami, G., Watabe, T., Takaoka, K., Miyazono, K. Imamura, T. 2003. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory SMADs. Mol. Biol. Cell 14, 2809 2817. (Pubitemid 36871523)
41. Nishita, M., Ueno, N. Shibuya, H. 1999. SMAD8B, a SMAD8 splice variant lacking the SSXS site that inhibits SMAD8-mediated signalling. Genes Cells 4, 583 591.
42. Pera, E. M., Ikeda, A., Eivers, E. De Robertis, E. M. 2003. Integration of IGF, FGF, and anti-BMP signals via SMAD1 phosphorylation in neural induction. Genes Dev. 17, 3023 3028. (Pubitemid 38040766)
43. Pierreux, C. E., Nicolas, F. J. Hill, C. S. 2000. Transforming growth factor beta-independent shuttling of SMAD4 between the cytoplasm and nucleus. Mol. Cell. Biol. 20, 9041 9054. (Pubitemid 32245933)
44. Roberts, A. B. Derynck, R. 2001. Meeting report: signaling schemes for TGF-beta. Sci. STKE 2001, PE43.
45. Serra, R. 2002. Transforming Growth Factor beta (TGFb). Encyclopedia of Life Science. John Wiley & Sons, Ltd
46. Shi, Y., Hata, A., Lo, R. S., Massague, J. Pavletich, N. P. 1997. A structural basis for mutational inactivation of the tumour suppressor SMAD4. Nature 388, 87 93. (Pubitemid 27283894)
47. Shi, Y. Massague, J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685 700. (Pubitemid 36724933)
48. Shi, Y., Wang, Y. F., Jayaraman, L., Yang, H., Massague, J. Pavletich, N. P. 1998. Crystal structure of a SMAD MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 94, 585 594. (Pubitemid 28427577)
49. Stegmuller, J., Huynh, M. A., Yuan, Z., Konishi, Y. Bonni, A. 2008. TGFbeta-SMAD2 signaling regulates the Cdh1-APC/SnoN pathway of axonal morphogenesis. J. Neurosci. 28, 1961 1969. (Pubitemid 351302668)
50. Takenoshita, S., Mogi, A., Nagashima, M. et al. 1998. Characterization of the MADH2/SMAD2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway. Genomics 48, 1 11. (Pubitemid 28110795)
51. Tao, S., Cai, Y. Sampath, K. 2009. The Integrator subunits function in hematopoiesis by modulating SMAD/BMP signaling. Development 136, 2757 2765.
52. Tsuneizumi, K., Nakayama, T., Kamoshida, Y., Kornberg, T. B., Christian, J. L. Tabata, T. 1997. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 389, 627 631. (Pubitemid 27446183)
53. Ueberham, U., Lange, P., Ueberham, E. et al. 2009. SMAD2 isoforms are differentially expressed during mouse brain development and aging. Int. J. Dev. Neurosci. 27, 501 510.
54. Ueberham, U., Ueberham, E., Gruschka, H. Arendt, T. 2006. Altered subcellular location of phosphorylated SMADs in Alzheimer's disease. Eur. J. Neurosci. 24, 2327 2334. (Pubitemid 44622353)
55. Wrana, J. L. 2000. Regulation of SMAD activity. Cell 100, 189 192.
56. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M. Miyazono, K. 1999. Alternatively spliced variant of SMAD2 lacking exon 3. Comparison with wild-type SMAD2 and SMAD3. J. Biol. Chem. 274, 703 709. (Pubitemid 129535225)